| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-04 03:40:29 UTC |
|---|
| Updated at | 2022-09-04 03:40:29 UTC |
|---|
| NP-MRD ID | NP0187496 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (1r,3r,6r,8s,10r,11s,12r,13s,16s,17r)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione |
|---|
| Description | Ginkgolide B belongs to the class of organic compounds known as ginkgolides and bilobalides. These are diterpene lactones with a structure based either on the gingkolide or the bilobalide skeleton. The ginkgolide skeleton is a very rigid structure consisting of hexacyclic C20 trilactone. The cis-fused F/A/D/C ring junction forms an empty semi-ball hole, the D ring contains a cage form tetrahydrofuran ring which occupies the center of the empty hole, and the oxygen atoms of the D,C and F ring and 10-hydroxyl group consist of an analogous crown ether structure. (1r,3r,6r,8s,10r,11s,12r,13s,16s,17r)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione is found in Ginkgo biloba. (1r,3r,6r,8s,10r,11s,12r,13s,16s,17r)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione was first documented in 2021 (PMID: 34944919). Based on a literature review a significant number of articles have been published on Ginkgolide B (PMID: 35276465) (PMID: 35343157) (PMID: 36044079) (PMID: 36015354) (PMID: 35948139) (PMID: 35922794). |
|---|
| Structure | C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@]34[C@H]5C[C@@H](C(C)(C)C)C33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O InChI=1S/C20H24O10/c1-6-12(23)28-11-9(21)18-8-5-7(16(2,3)4)17(18)10(22)13(24)29-15(17)30-20(18,14(25)27-8)19(6,11)26/h6-11,15,21-22,26H,5H2,1-4H3/t6-,7+,8-,9+,10+,11+,15+,17?,18-,19-,20-/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C20H24O10 |
|---|
| Average Mass | 424.4020 Da |
|---|
| Monoisotopic Mass | 424.13695 Da |
|---|
| IUPAC Name | Not Available |
|---|
| Traditional Name | Not Available |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@]34[C@H]5C[C@@H](C(C)(C)C)C33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O |
|---|
| InChI Identifier | InChI=1S/C20H24O10/c1-6-12(23)28-11-9(21)18-8-5-7(16(2,3)4)17(18)10(22)13(24)29-15(17)30-20(18,14(25)27-8)19(6,11)26/h6-11,15,21-22,26H,5H2,1-4H3/t6-,7+,8-,9+,10+,11+,15+,17?,18-,19-,20-/m1/s1 |
|---|
| InChI Key | SQOJOAFXDQDRGF-AFUSRUNCSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ginkgolides and bilobalides. These are diterpene lactones with a structure based either on the gingkolide or the bilobalide skeleton. The ginkgolide skeleton is a very rigid structure consisting of hexacyclic C20 trilactone. The cis-fused F/A/D/C ring junction forms an empty semi-ball hole, the D ring contains a cage form tetrahydrofuran ring which occupies the center of the empty hole, and the oxygen atoms of the D,C and F ring and 10-hydroxyl group consist of an analogous crown ether structure. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Terpene lactones |
|---|
| Direct Parent | Ginkgolides and bilobalides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ginkgolide-skeleton
- Diterpenoid
- Tricarboxylic acid or derivatives
- Furofuran
- Gamma butyrolactone
- Tetrahydrofuran
- Tertiary alcohol
- Cyclic alcohol
- Secondary alcohol
- Lactone
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Polyol
- Carboxylic acid derivative
- Acetal
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Liang H, Yuan X, Sun C, Sun Y, Yang M, Feng S, Yao J, Liu Z, Zhang G, Li F: Preparation of a new component group of Ginkgo biloba leaves and investigation of the antihypertensive effects in spontaneously hypertensive rats. Biomed Pharmacother. 2022 May;149:112805. doi: 10.1016/j.biopha.2022.112805. Epub 2022 Mar 8. [PubMed:35276465 ]
- He YQ, Zong CH, Wang J, Li Q, Wang J, Wu YJ, Chen Y, Liu XS: [Application of near infrared spectroscopy to predict contents of various lactones in chromatographic process of Ginkgo Folium]. Zhongguo Zhong Yao Za Zhi. 2022 Mar;47(5):1293-1299. doi: 10.19540/j.cnki.cjcmm.20211206.202. [PubMed:35343157 ]
- Samandar F, Tehranizadeh ZA, Saberi MR, Chamani J: CB1 as a novel target for Ginkgo biloba's terpene trilactone for controlling chemotherapy-induced peripheral neuropathy (CIPN). J Mol Model. 2022 Aug 31;28(9):283. doi: 10.1007/s00894-022-05284-8. [PubMed:36044079 ]
- Wang Q, Ma R, Liu P, Cheng G, Yang Q, Chen X, Wu Z, Yuan D, Chen T: Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease. Pharmaceutics. 2022 Aug 18;14(8):1731. doi: 10.3390/pharmaceutics14081731. [PubMed:36015354 ]
- Zhang J, Cheng J, Yan L, Yu Y, Hao C, Zhao A, Chen S, Liu A: Discovery of unreported ginkgolides of anti-PAF activity using characteristic ion and neutral loss recognition strategy in Ginkgo biloba L. Phytochemistry. 2022 Nov;203:113355. doi: 10.1016/j.phytochem.2022.113355. Epub 2022 Aug 7. [PubMed:35948139 ]
- Briskey D, Rao A: A double-blind, randomised cross-over study to evaluate the absorption of a commercially available Ginkgo biloba extract compared to the liposomal extract Ginkgosome. BMC Complement Med Ther. 2022 Aug 3;22(1):206. doi: 10.1186/s12906-022-03679-x. [PubMed:35922794 ]
- Luo T, Hao YN, Lin DD, Huang X, Wu AS: Ginkgolide B improved postoperative cognitive dysfunction by inhibiting microgliosis-mediated neuroinflammation in the hippocampus of mice. BMC Anesthesiol. 2022 Jul 18;22(1):229. doi: 10.1186/s12871-022-01750-1. [PubMed:35850641 ]
- Cao Y, Yang L, Cheng H: Ginkgolide B Protects Against Ischemic Stroke via Targeting AMPK/PINK1. Front Pharmacol. 2022 Jun 28;13:941094. doi: 10.3389/fphar.2022.941094. eCollection 2022. [PubMed:35837278 ]
- Jahan S, Redhu NS, Siddiqui AJ, Iqbal D, Khan J, Banawas S, Alaidarous M, Alshehri B, Mir SA, Adnan M, Pant AB: Nobiletin as a Neuroprotectant against NMDA Receptors: An In Silico Approach. Pharmaceutics. 2022 May 25;14(6):1123. doi: 10.3390/pharmaceutics14061123. [PubMed:35745697 ]
- Wang L, Xia K, Han L, Zhang M, Fan J, Song L, Liao A, Wang W, Guo J: Local Administration of Ginkgolide B Using a Hyaluronan-Based Hydrogel Improves Wound Healing in Diabetic Mice. Front Bioeng Biotechnol. 2022 May 25;10:898231. doi: 10.3389/fbioe.2022.898231. eCollection 2022. [PubMed:35694224 ]
- Zhang X, Diao X, Li L, Zhang Y, Liao M, Zhang G, Zhang L: Identification of metabolites of Ginkgolide B in vivo and in vitro using ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. J Sep Sci. 2022 Jul;45(14):2458-2477. doi: 10.1002/jssc.202101016. Epub 2022 May 18. [PubMed:35543088 ]
- Zhu J, Jin Z, Yang L, Zhao C, Hu J, Chen J, Han Y, Yu P, Luo J, Kong L, Zhang C: Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice. Pharmacol Res. 2022 Jun;180:106240. doi: 10.1016/j.phrs.2022.106240. Epub 2022 May 2. [PubMed:35513225 ]
- Zhao H, Guo Q, Li B, Shi M: The Efficacy and Safety of Ginkgo Terpene Lactone Preparations in the Treatment of Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Pharmacol. 2022 Mar 18;13:821937. doi: 10.3389/fphar.2022.821937. eCollection 2022. [PubMed:35392576 ]
- Cai D, Luo Z, Su J, Gan H, Wang Z, Liu X, Li S, Wu J, Chen J, Ma R, Huang M, Zhong G: Exposure-Response Analysis and Mechanism of Ginkgolide B's Neuroprotective Effect in Acute Cerebral Ischemia/Reperfusion Stage in Rat. Biol Pharm Bull. 2022;45(4):409-420. doi: 10.1248/bpb.b21-00781. [PubMed:35370265 ]
- Authors unspecified: Statement of Retraction: Hypoxia-induced apoptosis of cardiomyocytes is restricted by ginkgolide B-downregulated microRNA-29. Cell Cycle. 2022 Apr;21(7):757. doi: 10.1080/15384101.2021.2014708. Epub 2022 Feb 22. [PubMed:35191821 ]
- Zhu T, Wang L, Wang LP, Wan Q: Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: Applications for natural compounds from medicinal herbs. Biomed Pharmacother. 2022 Apr;148:112719. doi: 10.1016/j.biopha.2022.112719. Epub 2022 Feb 12. [PubMed:35168073 ]
- Shao L, Dong C, Geng D, He Q, Shi Y: Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer's disease. Metab Brain Dis. 2022 Feb;37(2):329-341. doi: 10.1007/s11011-021-00886-2. Epub 2022 Jan 20. [PubMed:35050445 ]
- Kawasaki K, Kasamatsu A, Ando T, Saito T, Nobuchi T, Nozaki R, Iyoda M, Uzawa K: Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway. Cancers (Basel). 2021 Dec 15;13(24):6299. doi: 10.3390/cancers13246299. [PubMed:34944919 ]
- LOTUS database [Link]
|
|---|